» Articles » PMID: 17151127

MUC1 Induced by Epstein-Barr Virus Latent Membrane Protein 1 Causes Dissociation of the Cell-matrix Interaction and Cellular Invasiveness Via STAT Signaling

Overview
Journal J Virol
Date 2006 Dec 8
PMID 17151127
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Disruption of cellular adhesion is an essential pathobiologic step leading to tumor dissemination. Mucin 1 (MUC1) is a mucinous glycoprotein expressed at the surfaces of epithelial cells in many tissues and their carcinomas. MUC1 plays crucial roles in tumor invasion and metastasis, especially in opposing cell adhesion. We have shown that virus infection, specifically by the human tumor virus Epstein-Barr virus (EBV) induces a spectrum of cellular invasiveness and metastasis factors. Here we show that expression of MUC1 is increased in diverse latently EBV-infected cell lines that express latent membrane protein 1 (LMP1), the main viral oncoprotein, and that the level of MUC1 was suppressed by expression of a dominant-negative mutant of LMP1. Expression of LMP1 in EBV-negative nasopharyngeal cell lines induces expression of MUC1 through activation of the MUC1 promoter via binding of STAT1 and STAT3. Finally, LMP1 reduces cell adhesion ability, which is restored by inhibition of MUC1 expression with MUC1 small interfering RNA (siRNA). In addition, LMP1 increases cell invasiveness, which is suppressed by MUC1 siRNA. Thus, LMP1 induces MUC1, a factor important in an early step of detachment and release of tumor cells, which along with induction of other invasiveness and angiogenic factors may combine to act in a complex sequential process that culminates in metastasis of EBV-infected tumor cells.

Citing Articles

Mucin Glycans: A Target for Cancer Therapy.

Sun L, Zhang Y, Li W, Zhang J, Zhang Y Molecules. 2023; 28(20).

PMID: 37894512 PMC: 10609567. DOI: 10.3390/molecules28207033.


Epstein-Barr virus infection: the micro and macro worlds.

Huang W, Bai L, Tang H Virol J. 2023; 20(1):220.

PMID: 37784180 PMC: 10546641. DOI: 10.1186/s12985-023-02187-9.


The multifaceted role of MUC1 in tumor therapy resistance.

Jin W, Zhang M, Dong C, Huang L, Luo Q Clin Exp Med. 2022; 23(5):1441-1474.

PMID: 36564679 DOI: 10.1007/s10238-022-00978-y.


Targeting cancer cell plasticity by HDAC inhibition to reverse EBV-induced dedifferentiation in nasopharyngeal carcinoma.

Xie J, Wang Z, Fan W, Liu Y, Liu F, Wan X Signal Transduct Target Ther. 2021; 6(1):333.

PMID: 34482361 PMC: 8418605. DOI: 10.1038/s41392-021-00702-4.


Unraveling mucin domains in cancer and metastasis: when protectors become predators.

Ganguly K, Rauth S, Marimuthu S, Kumar S, Batra S Cancer Metastasis Rev. 2020; 39(3):647-659.

PMID: 32488403 PMC: 7487023. DOI: 10.1007/s10555-020-09896-5.


References
1.
Zhang L, Hong K, Zhang J, Pagano J . Multiple signal transducers and activators of transcription are induced by EBV LMP-1. Virology. 2004; 323(1):141-52. DOI: 10.1016/j.virol.2004.03.007. View

2.
Shackelford J, Pagano J . Targeting of host-cell ubiquitin pathways by viruses. Essays Biochem. 2005; 41:139-56. DOI: 10.1042/EB0410139. View

3.
Pagano J, Blaser M, Buendia M, Damania B, Khalili K, Raab-Traub N . Infectious agents and cancer: criteria for a causal relation. Semin Cancer Biol. 2004; 14(6):453-71. DOI: 10.1016/j.semcancer.2004.06.009. View

4.
Hilkens J, Buijs F, Hilgers J, Hageman P, Calafat J, Sonnenberg A . Monoclonal antibodies against human milk-fat globule membranes detecting differentiation antigens of the mammary gland and its tumors. Int J Cancer. 1984; 34(2):197-206. DOI: 10.1002/ijc.2910340210. View

5.
Wang D, Liebowitz D, Kieff E . An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell. 1985; 43(3 Pt 2):831-40. DOI: 10.1016/0092-8674(85)90256-9. View